Hydrophobicity as a driver of MHC class i antigen processing

EMBO Journal

Volumn 30, Issue 8, 2011, Pages 1634-1644

  Huang, Lan ^a   Kuhls, Matthew C ^a   Eisenlohr, Laurence C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

degradation signal; ERAD; hydrophobicity; MHC class I peptides; transmembrane domain

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CHEMICAL LABELING; CYTOSOL; ENDOPLASMIC RETICULUM; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, LY; CYTOSOL; ENDOPLASMIC RETICULUM; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNOBLOTTING; MEMBRANE PROTEINS; MICE; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SORTING SIGNALS;

EID: 79955010364     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2011.62     Document Type: Article

References (50)

1. Arteaga MF, Wang L, Ravid T, Hochstrasser M, Canessa CM (2006) An amphipathic helix targets serum and glucocorticoid-induced kinase 1 to the endoplasmic reticulum-associated ubiquitin-conjugation machinery. Proc Natl Acad Sci USA 103: 11178-11183 (Pubitemid 44156492)
2. Bernasconi R, Galli C, Calanca V, Nakajima T, Molinari M (2010) Stringent requirement for HRD1, SEL1L, and OS-9/ XTP3-B for disposal of ERAD-LS substrates. J Cell Biol 188: 223-235
3. Carvalho P, Goder V, Rapoport TA (2006) Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell 126: 361-373 (Pubitemid 44092963)
4. Chianese-Bullock KA, Russell HI, Moller C, Gerhard W, Monaco JJ, Eisenlohr LC (1998) Antigen processing of two H2-IEd restricted epitopes is differentially influenced by the structural changes in a viral glycoprotein. J Immunol 161: 1599-1607 (Pubitemid 28387574)
5. Dolan BP, Li L, Takeda K, Bennink JR, Yewdell JW (2010) Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase. J Immunol 184: 1419-1424
6. Eisenlohr LC, Huang L, Golovina TN (2007) Rethinking peptide supply to MHC class I molecules. Nat Rev Immunol 7: 403-410 (Pubitemid 46674491)
7. Eisenlohr LC, Yewdell JW, Bennink JR (1992) Flanking sequences influence the presentation of an endogenously synthesized pep-tide to cytotoxic T lymphocytes. J Exp Med 175: 481-487
8. Gil-Torregrosa BC, Raul Castano A, Del Val M (1998) Major histo-compatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. J Exp Med 188: 11 0 5 - 111 6 (Pubitemid 28443334)
9. Gilon T, Chomsky O, Kulka RG (1998) Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae. EMBO J 17: 2759-2766 (Pubitemid 28227122)
10. Golovina TN, Morrison SE, Eisenlohr LC (2005) The impact of mis-folding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing. J Immunol 174: 2763-2769 (Pubitemid 40279692)
11. Golovina TN, Wherry EJ, Bullock TN, Eisenlohr LC (2002) Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum. J Immunol 168: 2667-2675 (Pubitemid 34211642)
12. Gregersen N, Bross P, Vang S, Christensen JH (2006) Protein misfolding and human disease. Ann Rev Genomics Human Genet 7: 103-124 (Pubitemid 44627924)
13. Gueguen M, Long EO (1996) Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen. Proc Natl Acad Sci USA 93: 14692-14697 (Pubitemid 26419030)
14. Hartl F-U, Hlodan R, Langer T (1994) Molecular chaperones in protein folding: the art of avoiding sticky situations. Trends Biochem Sci 19: 20-25 (Pubitemid 24028727)
15. Istrail S, Florea L, Halldorsson BV, Kohlbacher O, Schwartz RS, Yap VB, Yewdell JW, Hoffman SL (2004) Comparative immuno-peptidomics of humans and their pathogens. Proc Natl Acad Sci USA 101 : 13268-13272 (Pubitemid 39209654)
16. Johnson PR, Swanson R, Rakhilina L, Hochstrasser M (1998) Degradation signal masking by heterodimerization of MATalpha2 and MATa1 blocks their mutual destruction by the ubiquitin-proteasome pathway. Cell 94: 217-227 (Pubitemid 28348009)
17. Kang SW, Rane NS, Kim SJ, Garrison JL, Taunton J, Hegde RS (2006) Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway. Cell 127: 999-1013 (Pubitemid 44803063)
18. Lautscham G, Mayrhofer S, Taylor G, Haigh T, Leese A, Rickinson A, Blake N (2001) Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) Tcell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. J Exp Med 194: 1053-1068 (Pubitemid 32995777)
19. Metzger MB, Maurer MJ, Dancy BM, Michaelis S (2008) Degradation of a cytosolic protein requires endoplasmic reticulum-associated degradation machinery. J Biol Chem 283: 32302-32316
20. Meusser B, Hirsch C, Jarosch E, Sommer T (2005) ERAD: the long road to destruction. Nature Cell Biol 7: 766-772 (Pubitemid 41079045)
21. Ostankovitch M, Robila V, Engelhard VH (2005) Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that mis-folded full-length proteins are efficient substrates for class I processing and presentation. J Immunol 174: 2544-2551 (Pubitemid 40279667)
22. Peaper DR, Cresswell P (2008) Regulation of MHC class I assembly and peptide binding. Annu Rev Cell Dev Biol 24: 343-368
23. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN (1997) Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726 (Pubitemid 27305734)
24. Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, Buttgereit F, Bennink JR, Yewdell JW (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343-354 (Pubitemid 36351514)
25. Qian SB, Reits E, Neefjes J, Deslich JM, Bennink JR, Yewdell JW (2006) Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol 177: 227-233 (Pubitemid 43939134)
26. Raue U, Oellerer S, Rospert S (2007) Association of protein biogenesis factors at the yeast ribosomal tunnel exit is affected by the translational status and nascent polypeptide sequence. J Biol Chem 282: 7809-7816 (Pubitemid 47093553)
27. Reits EA, Vos JC, Gromme M, Neefjes J (2000) The major substrates for TAP in vivo are derived from newly synthesized proteins [see comments]. Nature 404: 774-778 (Pubitemid 30212406)
28. Romisch K (2005) Endoplasmic reticulum-associated degradation. Annu Rev Cell Dev Biol 21 : 435-456 (Pubitemid 41740642)
29. Schlosser E, Otero C, Wuensch C, Kessler B, Edelmann M, Brunisholz R, Drexler I, Legler DF, Groettrup M (2007) A novel cytosolic class I antigen-processing pathway for endoplasmic-reticulum-targeted proteins. EMBO Rep 8: 945-951 (Pubitemid 47500478)
30. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes [see comments]. Nature 404: 770-774 (Pubitemid 30212405)
31. Snyder HL, Bacik I, Bennink JR, Kearns G, Behrens TW, Bachi T, Orlowski M, Yewdell JW (1997) Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J Exp Med 186: 1087-1098 (Pubitemid 27441152)
32. Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81: 678-699 (Pubitemid 37491594)
33. Tobery T, Siliciano RF (1999) Induction of enhanced CTL-dependent protective immunity in vivo by N- end rule targeting of a model tumor antigen. J Immunol 162: 639-642 (Pubitemid 29035381)
34. Tobery TW, Siliciano RF (1997) Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J Exp Med 185: 909-920 (Pubitemid 27119875)
35. Townsend A, Bastin J, Gould K, Brownlee G, Andrew M, Coupar B, Boyle D, Chan S, Smith G (1988) Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 168: 1211-1224
36. Townsend ARM, Bastin J, Gould K, Brownlee GG (1986) Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence. Nature 324: 575-577 (Pubitemid 17185072)
37. Turner GC, Varshavsky A (2000) Detecting and measuring cotrans-lational protein degradation in vivo. Science 289: 2117-2120
38. Vabulas RM, Hartl FU (2005) Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310: 1960-1963 (Pubitemid 43005990)
39. Varshavsky A (1992) The N-end rule. Cell 69: 725-735
40. Vembar SS, Brodsky JL (2008) One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9: 944-957
41. Wheatley DN (1984) Intracellular protein degradation: basis of a self-regulating mechanism for the proteolysis of endogenous proteins. J Theor Biol 107: 127-149 (Pubitemid 14118252)
42. Wheatley DN, Giddings MR, Inglis MS (1980) Kinetics of degradation of 'short-' and 'long-lived' proteins in cultured mammalian cells. Cell Biol Int Rep 4: 1081-1090 (Pubitemid 11221748)
43. Wherry EJ, Puorro KA, Porgador A, Eisenlohr LC (1999) The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J Immunol 163: 3735-3745 (Pubitemid 29450896)
44. Wickner S, Maurizi MR, Gottesman S (1999) Posttranslational quality control: folding, refolding, and degrading proteins. Science 286: 1888-1893 (Pubitemid 129515889)
45. Wong SB, Buck CB, Shen X, Siliciano RF (2004) An evaluation of enforced rapid proteasomal degradation as a means of enhancing vaccine-induced CTL responses. J Immunol 173: 3073-3083 (Pubitemid 39142013)
46. Yewdell JW (2007) Plumbing the sources of endogenous MHC class I peptide ligands. Curr Opin Immunol 19: 79-86 (Pubitemid 46073699)
47. Yewdell JW, Antón LC, Bennink JR (1996) Defective ribosomal products (DRIPs): a major source of antigenic peptides for MHC class I molecules? J Immunol 157: 1823-1826 (Pubitemid 126449651)
48. Yewdell JW, Nicchitta CV (2006) The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol 27: 368-373 (Pubitemid 44038666)
49. Yewdell JW, Reits E, Neefjes J (2003) Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol 3: 952-961 (Pubitemid 37521537)
50. Zook MB, Howard MT, Sinnathamby G, Atkins JF, Eisenlohr LC (2006) Epitopes derived by incidental translational frameshifting give rise to a protective CTL response. J Immunol 176: 6928-6934 (Pubitemid 43787873)